-
Featured Authors
Corporate
- Biofuels & Climate Change
- Biotech Blog
- Business & Investments
- Business of Biotech
- Capital Business
- Corporate
- Environmental & Industrial
- Events
- Farmer Gene
- FierceBiotech
- Food & Agriculture
- Genome Alberta
- Health
- Inside BIO Industry Analysis
- IP Watchdog
- Life Science Leader
- One-on-One Compass
- Patent Baristas
- Patent Docs
- Patently BIOtech
- PharmTech Talk
- Public Policy
- Snapshot
- Trade Secrets Blog
Latest From Biotech Now
Innovative Companies and Investment Trends in Clean Tech at World Congress
A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 as deals are happening and attractive returns are generated. According to Reuters, “biotech IPOs have turned in a strong performance, delivering an average return of about 20 percent this year, compared with an average of 16 percent across all sectors.” This article focuses on IPOs for health biotech companies, but there is also a lot going on right now in Read More >
Roundtable Discussion Highlights Innovation, Commercial Reality for Renewable Chemical Products
Last week BIO brought together representatives from five renewable chemical companies that will be speaking at BIO’s World Congress on Industrial Biotechnology next month in Montreal for a roundtable discussion highlighting developments in the renewable chemical space. Bioformix, Itaconix, Newlight Technologies, Solegear and CO2 Solutions are all in the early stages of commercializing innovative renewable chemical products making it a very exciting time for the industry. “Renewable chemicals can already compete on cost with petroleum Read More >
Gene Patents, Angelina Jolie, and Reality
By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Angelina Jolie recently announced her personal connection with breast cancer and Myriad’s BRCA genetic test. While Jolie’s post was a commendable personal account of the real world impact of breast cancer and the real world impact of developments in healthcare technology, a few less informed individuals have tried to take advantage of this recent announcement from stardom and spread misinformation. Let’s Read More >
BIO Convention Post-Con, Plus a Look Ahead
Last month, the biopharma community gathered for the industry’s largest event, the BIO International Convention. We hope the event was successful for everyone who attended. We know it was a busy time for folks, especially based on the numbers from the Partnering System! Here is a quick recap: BIO One-on-One Partnering Stats for BIO2013 A total of 25,537 One-on-One Partnering meetings were scheduled at the event, officially beating last year’s record! Partnering Meeting Requests increased Read More >
Time Magazine Modifies the Endless Debate Over GM Crops
Bryan Walsh wrote for Time magazine about the so-called “obsession” surrounding genetically modified (GM) crops: “To environmentalist opponents, GM foods are simply evil, an understudied, possibly harmful tool used by big agribusiness to control global seed markets and crush local farmers. They argue that GM foods have never delivered on their supposed promise, that money spent on GM crops would be better funneled to organic farming and that consumers should be protected with warning labels Read More >
